International Grant Calls offer grants for AI research through partnerships between Singapore and other countries, as agreed at the national level. The goal of these calls is to foster collaboration between research communities in Singapore and overseas, leading to significant advancements in AI that benefit both parties. Proposals that receive funding must showcase strong partnerships, from the initial planning stages all the way through to execution, and must align with the shared research interests of both parties.
Current International Grant Call
AI Singapore (AISG) and the Institute for Information & Communication Technology Planning & Evaluation (IITP), South Korea have launched a joint grant call to provide funding for research on AI for Urban Cooling.
Click here for more details.
Past International Grant Calls
AI Singapore and the Ministry of Innovation, Science and Technology of the State of Israel (MOST) have launched a joint grant call totalling USD 1 million to support up to three (3) bilateral research proposals for up to 18 months on the topic of AI in Security and Fraud Prevention.
Click here for more details.
AI Singapore and the Institute for Information & Communication Technology Planning & Evaluation (IITP) of South Korea have launched a joint grant call to support research in AI for Net-Zero Energy Buildings.
Click here for more details.
Click here for more information on the awarded grant project.
Keen to collaborate on an International Grant Call?
If you would like to collaborate on an international grant call, please kindly forward your proposal to grantcall@aisingapore.org.
AI in Health Grand Challenge
The AI in Health Grand Challenge aims to encourage the development of innovative approaches that use artificial intelligence (AI) to enhance primary care in health promotion and disease management in Singapore and the world. It supports groundbreaking research ideas that adopt AI technologies and innovations to address the following challenge:
“How can Artificial Intelligence (AI) help primary care teams stop or slow disease progression and complication development in 3H – Hyperglycemia (diabetes), Hypertension (high blood pressure) and Hyperlipidemia (high cholesterol) patients by 20% in 5 years?”
